Clinical pharmacology and clinical trials of ribonucleotide reductase inhibitors: is it a viable cancer therapy?
about
Clinical pharmacology and clinical trials of ribonucleotide reductase inhibitors: is it a viable cancer therapy?
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh
2017年學術文章
@zh-hant
name
Clinical pharmacology and clin ...... is it a viable cancer therapy?
@en
Clinical pharmacology and clin ...... is it a viable cancer therapy?
@nl
type
label
Clinical pharmacology and clin ...... is it a viable cancer therapy?
@en
Clinical pharmacology and clin ...... is it a viable cancer therapy?
@nl
prefLabel
Clinical pharmacology and clin ...... is it a viable cancer therapy?
@en
Clinical pharmacology and clin ...... is it a viable cancer therapy?
@nl
P2860
P1476
Clinical pharmacology and clin ...... is it a viable cancer therapy?
@en
P2093
Mukundan Baskar Mannargudi
P2860
P2888
P304
P356
10.1007/S00432-017-2457-8
P50
P577
2017-06-17T00:00:00Z